The Procter & Gamble Company Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest
The Procter & Gamble Company (PG) reported Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest of $3.78 billion for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest · last filed 2024-04-19
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was $3.78B, a 10.43% increase year-over-year.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was $3.49B, a 11.77% decline year-over-year.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-09-30 was $4.56B, a 14.96% increase year-over-year.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for the quarter ending 2023-06-30 was $3.39B, a 10.92% increase year-over-year.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2023 was $14.74B, a 0.37% decline from fiscal 2022.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2022 was $14.79B, a 3.07% increase from fiscal 2021.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2021 was $14.35B, a 9.53% increase from fiscal 2020.
- The Procter & Gamble Company income (loss) from continuing operations, net of tax, including portion attributable to noncontrolling interest for fiscal 2020 was $13.10B, a 230.38% increase from fiscal 2019.
| Period end | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 3 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 6 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 9 month as first filed | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month | Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-03-31 | $3.78B 10-Q · filed 2024-04-19 | $7.27B derived: sum of 2 quarters · filed 2024-04-19 | $11.83B 10-Q · filed 2024-04-19 | $15.22B derived: sum of 4 quarters · filed 2024-04-19 | ||||
| 2023-12-31 | $3.49B 10-Q · filed 2024-01-23 | $8.05B 10-Q · filed 2024-01-23 | $11.44B derived: sum of 3 quarters · filed 2024-01-23 | $14.87B derived: sum of 4 quarters · filed 2024-04-19 | ||||
| 2023-09-30 | $4.56B 10-Q · filed 2023-10-18 | $7.95B derived: sum of 2 quarters · filed 2023-10-18 | $11.37B derived: sum of 3 quarters · filed 2024-04-19 | $15.33B derived: sum of 4 quarters · filed 2024-04-19 | ||||
| 2023-06-30 | $3.39B derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-04 | $6.82B derived: sum of 2 quarters · filed 2024-04-19 | $10.78B derived: sum of 3 quarters · filed 2024-04-19 | $14.74B 10-K · filed 2023-08-04 | ||||
| 2023-03-31 | $3.42B 10-Q · filed 2024-04-19 | $7.38B derived: sum of 2 quarters · filed 2024-04-19 | $11.35B 10-Q · filed 2024-04-19 | $14.40B derived: sum of 4 quarters · filed 2024-04-19 | ||||
| 2022-12-31 | $3.96B 10-Q · filed 2024-01-23 | $7.92B 10-Q · filed 2024-01-23 | $10.98B derived: sum of 3 quarters · filed 2024-01-23 | $14.35B derived: sum of 4 quarters · filed 2024-01-23 | ||||
| 2022-09-30 | $3.96B 10-Q · filed 2023-10-18 | $7.02B derived: sum of 2 quarters · filed 2023-10-18 | $10.39B derived: sum of 3 quarters · filed 2023-10-18 | $14.63B derived: sum of 4 quarters · filed 2023-10-18 | ||||
| 2022-06-30 | $3.06B derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-04 | $6.42B derived: sum of 2 quarters · filed 2023-08-04 | $10.67B derived: sum of 3 quarters · filed 2023-08-04 | $14.79B 10-K · filed 2023-08-04 | ||||
| 2022-03-31 | $3.37B 10-Q · filed 2023-04-21 | $7.61B derived: sum of 2 quarters · filed 2023-04-21 | $11.73B 10-Q · filed 2023-04-21 | $14.64B derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2021-12-31 | $4.24B 10-Q · filed 2023-01-19 | $8.37B 10-Q · filed 2023-01-19 | $11.28B derived: sum of 3 quarters · filed 2023-08-04 | $14.53B derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2021-09-30 | $4.13B 10-Q · filed 2022-10-19 | $7.03B derived: sum of 2 quarters · filed 2023-08-04 | $10.28B derived: sum of 3 quarters · filed 2023-08-04 | $14.17B derived: sum of 4 quarters · filed 2023-08-04 | ||||
| 2021-06-30 | $2.91B derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-04 | $6.16B derived: sum of 2 quarters · filed 2023-08-04 | $10.04B derived: sum of 3 quarters · filed 2023-08-04 | $14.35B 10-K · filed 2023-08-04 | ||||
| 2021-03-31 | $3.25B 10-Q · filed 2022-04-20 | $7.14B derived: sum of 2 quarters · filed 2022-04-20 | $11.44B 10-Q · filed 2022-04-20 | $14.23B derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2020-12-31 | $3.89B 10-Q · filed 2022-01-19 | $8.20B 10-Q · filed 2022-01-19 | $10.98B derived: sum of 3 quarters · filed 2022-08-05 | $13.94B derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2020-09-30 | $4.31B 10-Q · filed 2021-10-19 | $7.09B derived: sum of 2 quarters · filed 2022-08-05 | $10.05B derived: sum of 3 quarters · filed 2022-08-05 | $13.79B derived: sum of 4 quarters · filed 2022-08-05 | ||||
| 2020-06-30 | $2.79B derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-05 | $5.74B derived: sum of 2 quarters · filed 2022-08-05 | $9.49B derived: sum of 3 quarters · filed 2022-08-05 | $13.10B 10-K · filed 2022-08-05 | ||||
| 2020-03-31 | $2.96B 10-Q · filed 2021-04-20 | $6.70B derived: sum of 2 quarters · filed 2021-04-20 | $10.32B 10-Q · filed 2021-04-20 | $5.08B derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2019-12-31 | $3.74B 10-Q · filed 2021-01-20 | $7.36B 10-Q · filed 2021-01-20 | $2.12B derived: sum of 3 quarters · filed 2021-08-06 | $4.90B derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2019-09-30 | $3.62B 10-Q · filed 2020-10-20 | -$1.62B derived: sum of 2 quarters · filed 2021-08-06 | $1.16B derived: sum of 3 quarters · filed 2021-08-06 | $4.37B derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2019-06-30 | -$5.24B derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-06 | -$2.46B derived: sum of 2 quarters · filed 2021-08-06 | $755.00M derived: sum of 3 quarters · filed 2021-08-06 | $3.97B 10-K · filed 2021-08-06 | ||||
| 2019-03-31 | $2.78B 10-Q · filed 2020-04-20 | $5.99B derived: sum of 2 quarters · filed 2020-04-20 | $9.20B 10-Q · filed 2020-04-20 | $11.09B derived: sum of 4 quarters · filed 2020-04-20 | ||||
| 2018-12-31 | $3.22B 10-Q · filed 2020-01-23 | $6.43B 10-Q · filed 2020-01-23 | $8.32B derived: sum of 3 quarters · filed 2020-01-23 | $10.86B derived: sum of 4 quarters · filed 2020-01-23 | ||||
| 2018-09-30 | $3.21B 10-Q · filed 2019-10-22 | $5.10B derived: sum of 2 quarters · filed 2019-10-22 | $7.64B derived: sum of 3 quarters · filed 2019-10-22 | $10.20B derived: sum of 4 quarters · filed 2019-10-22 | ||||
| 2018-06-30 | $1.89B 8-K · filed 2018-10-22 | $4.43B derived: sum of 2 quarters · filed 2019-04-23 | $6.99B derived: sum of 3 quarters · filed 2019-04-23 | $9.86B 10-K/A · filed 2020-08-07 | ||||
| 2018-03-31 | $2.54B 10-Q · filed 2019-04-23 | $5.10B derived: sum of 2 quarters · filed 2019-04-23 | $7.97B 10-Q · filed 2019-04-23 | $10.17B derived: sum of 4 quarters · filed 2019-04-23 | ||||
| 2017-12-31 | $2.56B 10-Q · filed 2019-01-23 | $5.43B 10-Q · filed 2019-01-23 | $7.63B derived: sum of 3 quarters · filed 2019-01-23 | $10.19B derived: sum of 4 quarters · filed 2019-01-23 | ||||
| 2017-09-30 | $2.87B 8-K · filed 2018-10-22 | $5.07B derived: sum of 2 quarters · filed 2018-10-22 | $7.63B derived: sum of 3 quarters · filed 2018-10-22 | $10.19B derived: sum of 4 quarters · filed 2018-10-22 | ||||
| 2017-06-30 | $2.20B 8-K · filed 2018-10-22 | $4.76B derived: sum of 2 quarters · filed 2018-10-22 | $7.32B derived: sum of 3 quarters · filed 2018-10-22 | $10.19B 10-K · filed 2019-08-06 | ||||
| 2017-03-31 | $2.56B 8-K · filed 2018-10-22 | $5.12B derived: sum of 2 quarters · filed 2018-10-22 | $7.99B 10-Q · filed 2018-04-19 | $10.00B derived: sum of 4 quarters · filed 2018-10-22 | ||||
| 2016-12-31 | $2.56B 8-K · filed 2018-10-22 | $5.44B 10-Q · filed 2018-01-23 | $7.44B derived: sum of 3 quarters · filed 2018-10-22 | $9.78B derived: sum of 4 quarters · filed 2018-10-22 | ||||
| 2016-09-30 | $2.88B 8-K · filed 2018-10-22 | $4.88B derived: sum of 2 quarters · filed 2018-10-22 | $7.22B derived: sum of 3 quarters · filed 2018-10-22 | $10.13B derived: sum of 4 quarters · filed 2018-10-22 | ||||
| 2016-06-30 | $2.01B 10-K · filed 2017-08-07 | $4.34B derived: sum of 2 quarters · filed 2017-08-07 | $7.25B derived: sum of 3 quarters · filed 2017-08-07 | $10.03B 8-K · filed 2018-10-22 | ||||
| 2016-03-31 | $2.34B 10-K · filed 2017-08-07 | $5.24B derived: sum of 2 quarters · filed 2017-08-07 | $8.02B 10-Q · filed 2017-04-26 | $8.52B derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2015-12-31 | $2.90B 10-K · filed 2017-08-07 | $5.68B 10-Q · filed 2017-01-20 | $6.18B derived: sum of 3 quarters · filed 2017-08-07 | $8.58B derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2015-09-30 | $2.78B 10-K · filed 2017-08-07 | $3.27B derived: sum of 2 quarters · filed 2017-08-07 | $5.67B derived: sum of 3 quarters · filed 2017-08-07 | $8.35B derived: sum of 4 quarters · filed 2017-08-07 | ||||
| 2015-06-30 | $496.00M 10-K · filed 2016-08-09 | $640.00M 10-K · filed 2015-08-07 | $2.90B derived: sum of 2 quarters · filed 2016-08-09 | $5.57B derived: sum of 3 quarters · filed 2016-08-09 | $8.29B 10-K · filed 2017-08-07 | $8.93B 10-K · filed 2015-08-07 | ||
| 2015-03-31 | $2.40B 10-K · filed 2016-08-09 | $2.48B 10-Q · filed 2015-04-23 | $5.08B derived: sum of 2 quarters · filed 2016-08-09 | $7.79B 10-Q · filed 2016-04-26 | $8.29B 10-Q · filed 2015-04-23 | $10.24B derived: sum of 4 quarters · filed 2016-08-09 | ||
| 2014-12-31 | $2.67B 10-K · filed 2016-08-09 | $2.98B 10-Q · filed 2015-01-27 | $5.39B 10-Q · filed 2016-01-26 | $5.82B 10-Q · filed 2015-01-27 | $7.84B derived: sum of 3 quarters · filed 2016-08-09 | $10.27B derived: sum of 4 quarters · filed 2016-08-09 | ||
| 2014-09-30 | $2.72B 10-K · filed 2016-08-09 | $2.00B 10-Q · filed 2014-10-24 | $5.17B derived: sum of 2 quarters · filed 2016-08-09 | $7.59B derived: sum of 3 quarters · filed 2016-08-09 | $10.55B derived: sum of 4 quarters · filed 2016-08-09 | |||
| 2014-06-30 | $2.45B 8-K · filed 2015-10-26 | $2.61B 10-K · filed 2014-08-08 | $4.88B derived: sum of 2 quarters · filed 2015-10-26 | $7.83B derived: sum of 3 quarters · filed 2015-10-26 | $10.66B 10-K · filed 2016-08-09 | $11.71B 10-K · filed 2014-08-08 | ||
| 2014-03-31 | $2.43B 8-K · filed 2015-10-26 | $2.60B 10-K · filed 2014-08-08 | $5.38B derived: sum of 2 quarters · filed 2015-10-26 | $8.76B 10-Q · filed 2015-04-23 | $10.10B derived: sum of 4 quarters · filed 2015-10-26 | |||
| 2013-12-31 | $2.96B 8-K · filed 2015-10-26 | $3.47B 10-Q · filed 2014-01-24 | $6.23B 10-Q · filed 2015-01-27 | $6.53B 10-Q · filed 2014-01-24 | $7.67B derived: sum of 3 quarters · filed 2015-10-26 | $10.23B derived: sum of 4 quarters · filed 2015-10-26 | ||
| 2013-09-30 | $2.82B 8-K · filed 2015-10-26 | $3.06B 10-Q · filed 2013-10-25 | $4.72B derived: sum of 2 quarters · filed 2015-10-26 | $7.28B derived: sum of 3 quarters · filed 2015-10-26 | $11.31B derived: sum of 4 quarters · filed 2015-10-26 | |||
| 2013-06-30 | $1.89B 10-K · filed 2014-08-08 | $1.88B 10-K · filed 2013-08-08 | $4.46B derived: sum of 2 quarters · filed 2014-08-08 | $8.49B derived: sum of 3 quarters · filed 2014-08-08 | $10.35B 8-K · filed 2015-10-26 | $11.40B 10-K · filed 2013-08-08 | ||
| 2013-03-31 | $2.56B 10-K · filed 2014-08-08 | $2.59B 10-Q · filed 2013-04-24 | $6.60B derived: sum of 2 quarters · filed 2014-08-08 | $9.52B 10-Q · filed 2013-04-24 | $11.62B derived: sum of 4 quarters · filed 2014-08-08 | |||
| 2012-12-31 | $4.03B 10-K · filed 2014-08-08 | $4.08B 10-Q · filed 2013-01-25 | $6.93B 10-Q · filed 2014-01-24 | $9.06B derived: sum of 3 quarters · filed 2014-08-08 | $11.49B derived: sum of 4 quarters · filed 2014-08-08 | |||
| 2012-09-30 | $2.81B 10-K · filed 2014-08-08 | $2.85B 10-Q · filed 2012-10-25 | $5.03B derived: sum of 2 quarters · filed 2014-08-08 | $7.46B derived: sum of 3 quarters · filed 2014-08-08 | $9.13B derived: sum of 4 quarters · filed 2014-08-08 | |||
| 2012-06-30 | $2.21B 8-K · filed 2013-10-28 | $4.65B derived: sum of 2 quarters · filed 2013-10-28 | $6.32B derived: sum of 3 quarters · filed 2013-10-28 | $9.15B 10-K · filed 2014-08-08 | $9.32B 10-K · filed 2012-08-08 | |||
| 2012-03-31 | $2.43B 8-K · filed 2013-10-28 | $4.11B derived: sum of 2 quarters · filed 2013-10-28 | $7.10B 10-Q · filed 2013-04-24 | $9.57B derived: sum of 4 quarters · filed 2013-10-28 | ||||
| 2011-12-31 | $1.67B 8-K · filed 2013-10-28 | $4.67B 10-Q · filed 2013-01-25 | $7.14B derived: sum of 3 quarters · filed 2013-10-28 | $10.00B derived: sum of 4 quarters · filed 2013-10-28 | ||||
| 2011-09-30 | $3.00B 8-K · filed 2013-10-28 | $5.47B derived: sum of 2 quarters · filed 2013-10-28 | $8.33B derived: sum of 3 quarters · filed 2013-10-28 | $11.63B derived: sum of 4 quarters · filed 2013-10-28 | ||||
| 2011-06-30 | $2.47B 10-K · filed 2012-08-08 | $2.54B 8-K · filed 2012-02-10 | $5.33B derived: sum of 2 quarters · filed 2012-08-08 | $8.63B derived: sum of 3 quarters · filed 2012-08-08 | $11.70B 8-K · filed 2013-10-28 | $11.93B 8-K · filed 2012-02-10 | ||
| 2011-03-31 | $2.86B 10-K · filed 2012-08-08 | $2.91B 8-K · filed 2012-02-10 | $6.17B derived: sum of 2 quarters · filed 2012-08-08 | $9.23B 10-Q · filed 2012-04-27 | $11.43B derived: sum of 4 quarters · filed 2012-08-08 | |||
| 2010-12-31 | $3.31B 10-K · filed 2012-08-08 | $3.36B 8-K · filed 2012-02-10 | $6.37B derived: sum of 2 quarters · filed 2012-08-08 | $8.57B derived: sum of 3 quarters · filed 2012-08-08 | $11.19B derived: sum of 4 quarters · filed 2012-08-08 | |||
| 2010-09-30 | $3.06B 10-K · filed 2012-08-08 | $3.12B 8-K · filed 2012-02-10 | $5.27B derived: sum of 2 quarters · filed 2012-08-08 | $7.88B derived: sum of 3 quarters · filed 2012-08-08 | $11.07B derived: sum of 4 quarters · filed 2012-08-08 | |||
| 2010-06-30 | $2.20B 8-K · filed 2012-02-10 | $4.82B derived: sum of 2 quarters · filed 2012-02-10 | $8.00B derived: sum of 3 quarters · filed 2012-02-10 | $10.85B 10-K · filed 2012-08-08 | $11.06B 8-K · filed 2012-02-10 | |||
| 2010-03-31 | $2.62B 8-K · filed 2012-02-10 | $5.80B derived: sum of 2 quarters · filed 2012-02-10 | $8.85B derived: sum of 3 quarters · filed 2012-02-10 | |||||
| 2009-12-31 | $3.18B 8-K · filed 2012-02-10 | $6.24B derived: sum of 2 quarters · filed 2012-02-10 | ||||||
| 2009-09-30 | $3.06B 8-K · filed 2012-02-10 | |||||||
| 2009-06-30 | $10.77B 8-K · filed 2012-02-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| Longevity Health Holdings, Inc. (XAGE) | United States | $0.006B | -0.09 |